Human granulocytes are characterized by a variety of specific effector functions involved in host defense. Several widely expressed protein kinases have been implicated in the regulation of these effector functions. We employed a PCR-based strategy to identify novel granulocyte specific kinases. A novel protein kinase cDNA with an open
Introduction
Human polymorphonuclear leukocytes (PMN), which include neutrophilic and eosinophilic granulocytes, play an important role in host defense against invading microorganisms 1 . Recruitment and activation of these cells in vivo occurs in a multistep process that involves many different membrane bound receptors activating an array of diverse intracellular signaling molecules. In short, PMNs in the peripheral blood enter a pre-activated state by interacting with cytokines liberated from the inflammatory locus. This is followed by attachment to the endothelium, which is mediated by the interaction with adhesion molecules expressed on the surface of activated endothelial cells. Release of chemokines at the site of inflammation is responsible for the migration of PMNs to this locus. Finally upon recognition of the inciting agent by PMNs, phagocytosis, secretion of toxic proteins and activation of membrane bound NADPH-oxidase generating reactive oxygen intermediates ensues 2;3 . Furthermore, rapid induction of apoptosis in PMNs and subsequent removal of apoptotic cells are important in the rapid resolution of inflammation 4; 5 . An unfortunate consequence of activation in vivo is tissue damage during acute inflammation and, therefore, the activity of granulocytes is under tight control.
PMNs express a wide variety of receptors on their plasma membrane steering the process of priming and activation. Upon binding of inflammatory mediators, such as formyl peptides, lipopolysaccharides, chemokines or cytokines, the receptor transmits a signal to the cell interior resulting in the initiation of a cascade of intracellular events. Phosphorylation of effector molecules by kinases is critical for transducing intracellular signals. Thus far several classes of kinases including (i) serine kinases, such as mitogen activated (MAP) kinases; (ii) lipid kinases such as phosphatidylinositol-3 kinase (PI-3K); (iii) tyrosine kinases including the src kinases; (iv) cAMP-dependent kinases, and (v) Ca 2+ -dependent kinases, are activated in response to inflammatory mediators in human granulocytes.
A role for these widely expressed kinases in neutrophil functions has been intensively studied utilising pharmacological inhibitors. A role for MAP kinases, p42 ERK1 and p42 ERK2 in chemotaxis, respiratory burst and PAF release is suggested, although the use of a pharmacological inhibitor for MEK has resulted in contradictory findings 6; 7 . A clearer role for PI-3K in neutrophil migration and respiratory burst has been demonstrated by use of PI-3K
inhibitors wortmannin and LY294002 [7] [8] [9] [10] [11] . A role for PKC has also been postulated in a variety of granulocyte effector functions and PKA is suggested to be involved in down-regulating the respiratory burst 12; 13 . Recently a role for src kinases in adhesion-dependent degranulation has also been described 14 . Although inhibitory studies support a role for these kinases in regulating neutrophil functions, their activation is not specific for these granulocyte effector functions since they are widely expressed. Furthermore pharmacological inhibitors are often limited in their specificity, making the interpretation of data more complex 15 .
Changes in cytosolic free Ca 2+ are described during activation of several neutrophil responses, such as degranulation, respiratory burst and adhesion. An important role for Ca 2+ in these processes has been suggested 16; 17 and, therefore, Ca 2+ -dependent kinases may well be involved. In addition a role for the Ca 2+ -dependent phosphatase, calcineurin has been shown in the Ca 2+ -dependent recycling of integrins to the front of migrating neutrophils 18 , while a role for calmodulin and CaMKII is suggested in O 2 -production 19 . In this report we describe the identification of a novel protein kinase, which we have termed CKLiK (CaMKI-like kinase). This kinase is predominantly expressed in human PMNs and is regulated by Ca 2+ and calmodulin.
Interleukin-8 (IL-8), which is a potent activator of neutrophil effector functions, induces activation of CKLiK and we show that an inducible active mutant of CKLiK induces ERK MAP kinase activation. These data identify a novel Ca 2+ /calmodulin-dependent protein kinase expressed in PMNs that may play a role in transducing chemokineinduced signals regulating human granulocyte functions. 
Materials and Methods

Cells
Identification and cloning of granulocyte kinases
For the identification of novel kinases in human granulocytes PCR was performed using degenerate primers as previously described 21 . Forward primers were based around the consensus amino acid sequence HRDLKPEN, which corresponded to the conserved regions in the serine/threonine protein kinase catalytic domain. Full-length cDNA was obtained by screening a λZAPII eosinophilic library 22 with the amplified PCR fragment as a probe. After plaque purification, the pBluescript SK-phagemids containing positive inserts were isolated by in vivo excision using M13K07 helper phages (Promega Corporation, Madison, WI, USA), and subsequently characterized by restriction mapping and sequencing.
Isolation human leukocytes
Blood was obtained from healthy volunteers at the donor service of the University Medical Center (Utrecht the Netherlands). Granulocytes were isolated from 0.4% (wt/vol) trisodium citrate (pH 7.4) treated blood as previously described 23 . In short, mononuclear cells were removed from granulocytes by centrifugation over isotonic Ficoll from Pharmacia (Uppsula, Sweden). After lysis of the erythrocytes in an isotonic NH 4 Cl solution, neutrophils were washed and resuspended in incubation buffer (20mM HEPES, 132mM NaCl, 6mM KCl, 1mM MgSO 4 , 1.2mM KH 2 PO 4 , 5mM glucose, 1mM CaCl 2 ). Granulocytes were incubated for 30 minutes at 37 0 C before experiments were performed. Monocytes were further separated from mononuclear lymphocytes by elutriation as described previously 24 .
Isolation and differentiation of CD34 + stem cells CD34 + cells were isolated using the MACS CD34 + progenitor cells isolation kit from Miltenyi Biotech (Auburn, CA). First mononuclear cells were isolated from human umbilical cord blood cells by density centrifugation over a Ficoll solution. Cells were blocked and additionally incubated with a CD34 antibody in a phosphate buffer containing 2mM EDTA and 0,5% BSA (Buffer M). Magnetic beads recognizing the CD34 antibody were added and the suspension was applied to an MS + separation column placed in the magnetic cell separator MiniMACS. CD34 -cells were allowed to pass through the column by three wash steps with buffer M. CD34 + cells were eluted with buffer M by removal of the column from the separator. To obtain a pure CD34 + cell population the magnetic separation step was repeated on a second column. After final elution stem cells were counted and cultured. Before differentiation, CD34 + stem cells were proliferated for one week in the presence of TPO (10ng/ml), SCF (50ng/ml), FLT-3 ligand (50ng/ml) and IL-6 (2ng/ml). At day 0 differentiation was started by addition of SCF, FLT-3 ligand, IL-3 (10ng/ml) and G-CSF (30ng/ml). At day 3, 7, 10, 14 and 17 IL-3 and G-CSF were added and at day 21 only G-CSF was added to the cells. At each point cells were counted, diluted to 0.5*10 6 cells/ml and if possible samples were taken for mRNA isolation.
RNaseProtection
Total mRNA from human monocytes, lymphocytes, granulocytes and hematopoietic cell lines HL60, U937 and THP1 were isolated. In short, 10 8 cells were lysed in 2ml GIT-C solution (6M guanidine thiocyanate, 25mM sodiumcitrate, 0.5%N'Lauroyl-sacosine, 100mM β-mercapto-ethanol) and RNAs were further isolated by phenol extraction and ethanol precipitation.
32
P-UTP labelled antisense RNA transcript, corresponding to the original PCR fragment coding the catalytic domain of CKLiK, was generated using the Riboprobe in vitro Transcription system (Promega Corporation, Madison, WI, USA) and used as a RNA-probe. As internal control a 90 bp antisense RNA probe of GAPDH was used. Total RNAs samples (10µg) were lyophilised and resuspended in 2µl DEPC water.
Hybridisation was performed with 10 5 cpm of each antisense RNA probe in 25µl 80% formamide, 40mM PIPES pH 6.4, 400mM NaCl and 1mM EDTA overnight at 45 0 C. Subsequently probes were incubated for 1 hour in RNAse buffer (10mM Tris-Cl pH 7.5, 5mM EDTA, 300mM NaCl supplemented with 0.15µl/ml T1 RNase) at 37 0 C to degrade unhybridised RNA. The reaction was stopped by addition of 10µl proteinase K (5mg/ml) and 10% SDS. Hybridised (double stranded) RNA was purified by phenol-extraction and ethanol precipitation. The remaining pellet was resuspended in 2µl DEPC water and 2µl RNA loading buffer (80% formamide, 10mM EDTA, 1 mg/ml xylene cyanol, 1 mg/ml bromphenol blue). Samples were heated for 5 minutes at 95 0 C and analyzed by polyacrylamide gel electrophoresis.
DNA constructs
Epitope-tagged CKLiK was generated by PCR using the oligonucleotides forward XhoI; 5'-CCGCTCGAGTATGGCCCGGGAGAACGGC-3' and reverse KpnI; 5'-CCGGTACCCAAGTAG-CTGACATTACAGG-5') and ligated by XhoI/KpnI digest into pMT-HA. HA_CKLiK-309 and HA_CKLiK-296 were also generated by PCR using reverse primers introducing a stopcodon at amino acid 310 or 297 (309:5'-GCATTTCATGCTTGGCACCATT-3',296; 5'-GCTCTAGATCACTGGGCGCTGACG GACTC-3 '). PCR products were cloned into pGEM-T vector and subcloned into pMT2-HA vector. GFP-tagged CKLiK was generated by PCR and recloned in frame into pEGFP-C2 vector (Clontech Laboratories Inc., California, USA). HA_CKLiK was cloned from pMT-HA into pBabe 25 by BamHI/ EcoRI digest. Untagged CKLiK-296 was obtained by PCR cloned and into pSG5 26 . VSV tagged CaMKKα was generated by PCR on rat brain tissue cDNA using the oligonucleotides 5'-CAGTCGACCAGGAATATCC ACGGACTGA-3' and 5'-ATAGCGGCCGCCGGATGCAGCCTCATCTTC-3' and cloned into the pMT2-VSV vector. Tamoxifen inducible CKLiK construct, ER_CKLiK-296 was generated by PCR and cloned into the pCDNA3-ER-N vector. The constructs for HA_PKB and HA_ERK have been previously described 27 . CREB_GAL4, CREBS133A_GAL4, GAL4CAT constructs were previously described in 28 .
In vitro kinase assay
COS cells were transiently transfected with 10µg of HA-tagged CKLiK-WT, CKLiK-309 or CKLiK-296 using calcium phosphate precipitation and the medium refreshed 16 hours later. For the CKLiK kinase assay, 24 hours later cells were stimulated with or without ionomycin for 5 minutes, washed twice with cold PBS and lysed in a buffer containing, 1% NP-40, 20mM Tris-Cl pH 7.5, 150mM NaCl, 10% glycerol and 10mM MgCl 2 supplemented with 10µg/ml aprotinin, 1mM leupeptin, 1mM PMSF, 1mM benzamidine and 1mM Na 3 VO 4 . 32D cells stably expressing CKLiK-WT, were mIL-3 and serum starved for 4 hours and stimulated with hIL-8 (10 CaCl 2 and 0.5µg calmodulin, 5µg CREMβ (33kDa) or mutated CREMτ-S117A (42kDa) as substrate 29 . PKB and ERK kinase assay were performed as described previously 27 .
CAT assay
COS cells were transiently transfected with 4µg CKLiK-WT, -309 or -296, together with 2µg CREB_GAL4 or CREB-S133A_GAL4 fusion expression plasmids and 2µg GAL4CAT reporter construct using calcium phosphate precipitation. After 16 hours cells were washed twice and medium refreshed. Eight hours later cells were incubated overnight with 1µM ionomycin. Cells were lysed by repeated freeze-thawing in 100 µl 250mM Tris-Cl pH7.4 and 25mM EDTA. 50µl of cellular extract was incubated in a total volume of 100µl containing 250mM Tris-Cl 7.4, 2% glycerol, 0.3mM Butyryl Coenzyme A and 0.05µCi 14 C-Chloramphenicol for 2 hours at 37 0 C. Reaction products were extracted using 400µl xylene/pristane (1:2) and the percentage of acetylated products was determined using liquid scintillation counting. A lacZ reporter was used to correct for transfection efficiency. Data represent at least 3 independent experiments ± SEM.
Detection of GFP fusion-protein localization
Plasmids encoding CKLiK and active CKLiK-296 containing N-terminal enhanced Green Fluorescent were transiently transfected in COS cells which were grown on coverslips. 36 hours after transfection COS cells were washed with PBS, fixed with 70 % ice-cold methanol, and examined by fluorescence microscopy.
Western blotting
After stimulation 10 6 neutrophils/point were lysed in 1x Laemmli sample buffer. Protein samples were separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore). The membranes were probed with anti-phospho-CREB-Ser133 antibodies (New England Biolabs Inc., Beverly, MA, USA) and swine anti-rabbit peroxidase-conjugated antibodies (DAKO, Denmark), following detection by enhanced chemiluminescence (ECL, Amersham). Protein kinase expression controls were performed by utilizing 12CA5 and rabbit anti-mouse peroxidase conjugated antibodies (DAKO, Denmark) to detect HA_CKLiK, HA_ERK and HA_PKB. Detection of CaMKK-VSV was performed with anti-VSV antibodies and swine anti-rabbit peroxidaseconjugated antibodies. Hybridization's were followed by detection with enhanced chemiluminescence (ECL, Amersham).
Results
Cloning and expression of CKLiK
While several kinases have been implicated in the control of granulocyte effector functions 12; 30 , most of these proteins are widely expressed. To identify novel granulocyte specific kinases, degenerate primers against conserved kinase catalytic domains were utilized as previously described 21 . The central core of the catalytic domain consists of subdomains VI and IX and contains two well-conserved amino acid triplets APE and DGF 31 . Degenerate oligonucleotides were designed against subdomains VI and IX and used in a PCR on cDNA of human PMNs. Under stringent conditions PCR products of approximately 200bp were amplified, cloned and sequenced. All cloned PCR products contained the two conserved amino acid triplets and many were identical to previously identified kinases (data not shown). However one clone exhibited homology with Calcium/Calmodulin-dependent kinase I (CaMKI) and subsequently termed CKLiK (CaMKI Like Kinase).
To isolate full-length CKLiK cDNA, a human eosinophil library was screened with the amplified PMN cDNA PCR fragment. Several positive clones were isolated and sequenced, and one cDNA of 1.7 kb contained a 357 amino acid open reading frame encoding a protein of 40 kDa as determined by in vitro transcription/translation (data not shown). In Figure 1 the complete cDNA and the translated amino acid sequence is depicted. The context of the ATG codon was in good agreement with eukaryotic translation start-sites 32 . As shown in Figure 2a comparison of the predicted CKLiK protein sequence in BLAST database revealed a 77% homology of CKLiK with CaMKI on amino acid level. The greatest divergence between the two sequences occurs at the N-and C-terminus.
To determine the distribution of CKLiK expression we analyzed mRNA levels in primary human leukocytes and hematopoietic cell lines by RNase protection (Fig. 2b) . mRNA from lymphocytes, which includes T and B-cells, monocytes and PMNs were analyzed. Additionally three myeloid cell lines HL60 (promyelocytic leukemia), U937 (histiocytic lymphoma) and THP1 (acute monocytic leukemia) were analysed for CKLiK expression. As an internal control we utilized a GAPDH probe (Fig 2b; lower panel) . Human PMNs contain high levels of CKLiK ( Fig.2b ; lane 3), while little to no expression was observed in monocytes and lymphocytes ( Fig. 2b; lane 1-2 ). In the different lymphoid and myeloid cell lines we couldn't detect CKLiK (Fig. 2b ; lane 4-6). Since CKLiK expression is apparently only detected in mature myeloid cells, we analyzed the expression of CKLiK during differentiation of CD34 + cord blood stem cells towards the neutrophilic lineage. Although after ten days of differentiation CKLiK mRNA was present, increased mRNA levels are indeed detected during terminal differentiation at day 28 (Fig 2c) . Similar results were obtained during the differentiation towards eosinophils in the presence of interleukin-5 (data not shown). Full-length sequence of the novel kinase was obtained by screening an eosinophil cDNA λZAPII phage library using the initial degenerate PCR product as a probe. Sequencing was performed and the open reading frame was analyzed.
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CKLiK kinase activity was analyzed by in vitro kinase assay, utilizing CREM as a substrate and by transcriptional reporter assays utilizing CREB_GAL4 fusion constructs 28 . CKLiK was immunoprecipitated from transfected COS cell lysates and immunecomplex kinase assays performed (Fig 3a) . CREMβ (33kDa) or a mutant CREMτ (42kDa) which has a serine to an alanine substitution on position 117 (CREMτ-S117A), were utilized as substrates (Fig. 3a) . Due to the different size of the two isoforms, this allows the specific phosphorylation of Ser-117 to be analyzed within a single assay. The assay was performed in the absence or presence of Ca 2+ and calmodulin. As a positive control for this assay we utilized recombinant CaMKI, which potently phopshorylated CREMβ. Due to the high level of recombinant CaMKI, some background phosphorylation of the mutated form of CREM (CREMτ-S117A)
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For transcriptional reporter assays, cells were transfected with HA_CKLiK, a GAL4-CAT reporter construct in combination with a CREB_GAL4 fusion construct or a mutant thereof, in which the phosphorylation site (serine-133) is substituted by an alanine (CREB-S133A_GAL4) (Fig. 3b) . Ionomycin treatment resulted in a 5-fold induction of reporter-activity in cells expressing CKLiK with only a modest increase in control cells ( Fig. 3b ; left panel). CKLiK had no effect when using the mutant form of CREB (Fig 3b; right panel) . These results demonstrate that CKLiK is regulated by Ca 2+ /calmodulin and that active CKLiK can directly phosphorylate CREM, and activate CREB enhancing it's transactivation capacity.
C-terminal truncation of CKLiK results in a constitutively active mutant
Sequence alignment with CaMKI and the results described above suggests that CKLiK contains a calmodulin binding domain regulating its activity. To investigate this hypothesis we generated two truncation mutants (Fig. 4a) . Truncation of the predicted calmodulin-binding domain (CKLiK-309) should result in an inactive kinase. Indeed mutant CKLiK-309, lacking residues 310-357, remains inactive even in the presence of Ca 2+ /calmodulin, unable to phosphorylate CREM (Fig. 4b) or to activate CREB mediated transcription after ionomycin stimulation (Fig. 4c) . However, if CKLiK also contains an auto-inhibitory domain similar to CaMKI then, removal of this domain (CKLiK-296) should generate a constitutively active kinase. As was predicted truncation of residues 297-357 generated a constitutively active CKLiK. CREM was phosphorylated by CKLiK-296 in the absence of Ca 2+ /calmodulin (Fig. 4b) and CKLiK-296 greatly enhanced CREB mediated transcription, which was not further enhanced by ionomycin addition (Fig 4c) . Since we demonstrated that activated CKLiK could phosphorylate CREM and activate CREB mediated transcription we were interested to determine whether CKLiK was located in the cytoplasm or nucleus. We generated Green /calmodulin as indicated. CREMβ-WT (33kDa) and mutated CREMτ-S117A (42kDa) were used as substrate. Data represent one of four independent experiments. (B) Cells transfected with GAL4-CAT reporter construct (2µg) and fusion construct of CREB_GAL4 or CREB-S133A_GAL4 (2µg) (indicated as CREB-WT and CREB-S133A respectively), were co-transfected, with CKLiK (4µg) or with control vector as indicated. Stimulation with or without 1µM ionomycin and CAT reporter assays were performed as described in Materials and Methods. Data are indicated as counts per minute (cpm) and represent at least three independent experiments ± S.E.M.
A B
CREB-WT CREB-S133A Fluorescent Protein (GFP) containing fusion constructs of CKLiK-wt and the active CKLiK-296. COS cells were grown on coverslips and transfected with CKLiK and CKLiK-296 containing N-terminal GFP fusion. Localization was examined by fluorescence microscopy (Fig. 4d) . GFP-CKLiK was clearly located in the cytoplasm, whereas the active form of CKLiK exhibited a strong nuclear fluorescence. Since the active form of CKLiK is detected in the nucleus it suggests that CKLiK may regulate transcription through nuclear localization.
Ca 2+ /calmodulin kinase kinaseα enhances CKLiK activity
Although the binding of Ca 2+ /calmodulin is known to activate CaM kinases, an additional activation of CaMKI and CAMKIV by CAMK kinase (CAMKK) has previously been described [36] [37] [38] . CaMKK phosphorylates CAMKI and CaMKIV in the activation-loop at position Thr-177 and Thr-196/Thr-200 respectively, stabilizing and thereby enhancing kinase activity. CKLiK contains a threonine at position 180 in alignment with Thr-177 of CaMKI and Thr-200 of CAMKIV. To investigate the effect of CAMKKα on the CKLiK activity we performed kinase and reporter assays. Co-transfection of CaMKKα with CKLiK resulted in an enhanced CREM phosphorylation ( Fig. 5a; right panel). In the absence of Ca 2+ /calmodulin in the kinase assay, CaMKKα enhanced CKLiK induced CREM phosphorylation ( Fig. 5a; left panel) . Similar results were found utilizing reporter assays (Fig. 5b) . Co-transfection of CKLiK with CaMKKα resulted in an elevated reporter activity both in untreated ( Fig. 5b; left panel) and ionomycin treated cells ( Fig. 5b; right panel) . CaMKKα alone had no effect on CAT activity, suggesting that CREB_GAL4 and CKLiK (4µg) were co-transfected without or with CaMKKα (2µg) as indicated. CaMKKα was transfected without CKLiK as a negative control. 18 hours prior to harvesting, cells were stimulated with or without 1µM ionomycin and reporter-assays were performed. Data represent at least three independent experiments ± S.E.M and are corrected for transfection efficiency.
Activation of CKLiK by IL-8 in bone marrow derived myeloid precursor cells
Since agonist stimulation of G-protein coupled receptors results in changes of [Ca 2+ ] i , these receptors are potential activators of CKLiK. The IL-8 receptor is highly expressed on human neutrophils and IL-8 can activate neutrophil effector functions, such as chemotaxis. In order to investigate whether IL-8 can activate CKLiK, we utilized a 32D model system. 32D cells are IL-3-dependent bone marrow derived myeloid precursor cells 40 . Since these cells express endogenous IL-8R 41 we generated stable 32D cell lines expressing HA_CKLiK and used these cells to measure IL-8 induced CKLiK activity. IL-8 was indeed able to induce an increase in intracellular Ca 2+ in these cells (Fig. 6a) . IL-8 stimulation of HA_CKLiK expressing 32D cells, resulted in a rapid transient increased CKLiK activation (Fig. 6b) , whereas in Ca 2+ -depleted cells, IL-8 induced CKLiK activity was completely abolished (data not shown). CKLiK activation parallels the rise in intracellular Ca 2+ induced by IL-8 (Fig. 6a) . Additionally, W7, an antagonist of calmodulin completely inhibited the IL-8 induced CKLiK activity (Fig 6c) . CKLiK activity was also inhibited by W7 in the ionomycin treated cells, indicating that calmodulin is indeed critical for the CKLiK kinase activity stimulated by agents, which induce a Ca 2+ influx. 
Activation of downstream signaling pathways by CKLiK
To identify potential downstream targets of CKLiK, we analyzed the effect of CKLiK on the activation of the ERK1 MAP kinase and Protein kinase B (PKB), an effector of PI-3K. The regulation of ERKs and PKB by [Ca 2+ ] i has been demonstrated in several systems 42; 43 . Cells were transfected with HA-tagged-ERK or -PKB and co-transfected with constitutively active CKLiK (CKLiK-296) or CaMKKα and immunecomplex kinase assays were performed. Stimulation with 20% FCS for 10 minutes was used as a positive control. Co-transfection of CKLiK-296 had no effect on PKB activity, while co-transfection of CaMKKα potently activated PKB similar to levels induced by 20% FCS ( Fig. 7a; upper panel) . This is in agreement with the direct PKB phosphorylation by CaMKK described by Yano et al. 42 . Interestingly however, co-transfection of constitutively active CKLiK-296 resulted in an increase in ERK1 activation ( Fig. 7a; lower panel) . To avoid the possibility of autocrine effects due to over-expression of active CKLiK, we constructed a tamoxifen-inducible active CKLiK (ER_CKLiK-296). When transfected into cells, ER_CKLiK-296 is actively repressed by binding of heat-shock proteins. Upon addition of the oestrogen derivate, 4-hydroxy-tamoxifen (4-OHT), heat-shock proteins dissociate and CKLiK-296 is directly activated 44 . This system has been successfully utilized for other protein kinases 45 . Cells were transfected with ER_CKLiK-296 and HA epitope tagged ERK1 or PKB. Prior to harvesting cells were stimulated with 4-OHT and ERK/PKB kinase activity was measured. After two minutes of treatment an increased ERK activation was detected, whereas no PKB activation occurred (Fig. 7b) . The CKLiK induced ERK activity could be blocked by the MEK inhibitor PD98059 (Fig. 7c) , suggesting that CKLiK activates signaling molecules upstream in the MAPK pathway. Thus, these results suggest a role for CKLiK in regulation of ERK MAPK kinases at the level of MEK or higher.
Discussion
In this paper we describe the identification and characterization of a novel protein serine kinase which is highly expressed in human PMNs. These cells, which include neutrophils and eosinophils, are characterized by a variety of specific effector functions that regulate host defense. While several protein kinases, have been previously postulated to regulate some of these effector functions through pharmacological inhibition studies, these proteins are ubiquitously expressed and thus more likely to be involved in general cellular processes. Furthermore the use of pharmacological inhibitors is often complicated by aspecific effects 15; 46 . By utilizing degenerate PCR primers against conserved catalytic kinase domains in a polymerase chain reaction on cDNA templates from human granulocytes, we have identified a novel protein kinase with an open reading frame of 357 amino acids (Fig.1 ). This novel kinase shows homology with Calcium/calmodulin-dependent Kinase I (CaMKI) and therefore we have termed this kinase CaMKI-like kinase (CKLiK). CaMKI belongs to the family of Ca 2+ and calmodulin-dependent kinases, which includes CaMK I, II and IV as well as myosin light chain kinase, phosphorylase kinase and elongation factor 2 kinase 47; 48 . CaMKI itself has a wide tissue distribution and can phosphorylate a number of substrates in vitro, including the synaptic vesicle-associated proteins synapsin 1 and synapsin 2 49 and cAMP response element binding protein (CREB) 28 . Interestingly, analysis of CKLiK mRNA in hematopoietic cells, revealed high and almost exclusive expression levels in PMNs, suggesting a role for CKLiK in human granulocytes (Fig. 2) Figure 4 ). Additionally we show that CKLiK can directly activate two members of the CREB/ATF family of transcription factors, CREM and CREB by phosphorylation of serine residues 117 and 133 respectively (Fig. 3) . Although CKLiK is located in the cytoplasm, the constitutively active mutant was clearly translocated to the nucleus (Fig. 4d ). Possibly this enhanced nuclear translocation uncouples CKLiK from normal regulation resulting in enhanced transcriptional activation. For CaMKIV it has been suggested that it can phosphorylate CREB in vivo since it shows nuclear localisation 52 . Although a role for CREB in myeloid cells has been proposed in mediating cytokine or chemokine effector functions [53] [54] [55] [56] , it remains to be determined if CREB and CREM are physiological substrates for CKLiK in human granulocytes. Indeed we were able to demonstrate CREB phosphorylation by IL-8 in human PMNs (data not shown).
Co-transfection of CaMK kinase (CaMKKα) resulted in an enhanced CKLiK activity measured by in vitro phosphorylation of CREM and in vivo CREB mediated transcription activation. Enhancement of CKLiK activity by CaMKK is possible via phosphorylation of the threonine residue on position 180, since this is in consensus with threonine residues 177 and 196/200 of CaMKI and CaMKIV respectively. Interestingly CaMKKα induced CKLiK activity in the absence of Ca 2+ in the in vitro kinase assay (Fig. 5 ). There is indication of the generation of Ca 2+ -independent CaMKIV activity by CaMKKα, however this is not the case for CaMKI 33; 39 . What the mechanism is for generating this enhanced CKLiK activity is unclear, although this may be a relevant in vivo. As previously mentioned it may be due to stabilization of the CKLiK-Ca 2+ -calmodulin complex allowing for example a prolonged kinase activity similar to the regulation of CaMKII 57 , which might be needed for regulation of transcription. IL-8 induced CKLiK activation is very rapid and corresponded to the IL-8 induced rise in [Ca 2+ ] i (Fig. 6) . The IL-8 receptor is highly expressed on human neutrophils and could be a possible upstream physiological receptor for CKLiK. IL-8 is known to induce chemotaxis, and recently a role for intracellular Ca 2+ in IL-8 induced migration has been described indicating a possible role of CKLiK in this process 58; 59 . A role for Ca 2+ and calmodulin-dependent kinases in apoptosis has also been recently demonstrated, since CaMKK was found to directly activate PKB and thereby rescue apoptosis 42 . While we found no activation of PKB by CKLiK, we demonstrated an elevated ERK activity by inducing CKLiK activation, which could be blocked by the MEK inhibitor PD098059 (Fig. 7) . As previously eluded to, pharmacological inhibitory studies have suggested that ERK MAP kinases possibly play a role in chemotaxis, or respiratory burst and PAF release 6; 7; 60 . The mechanism by which CKLiK can activate ERKs however remains to be resolved, although it presumably occurs upstream of ERK.
In conclusion the approach of degenerate PCR resulted in a successful isolation of a novel PMN protein kinase. We have demonstrated that this kinase is highly and predominantly expressed in human PMNs and terminally 
